Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2012; 18(19): 2390-2395
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2390
Table 1 Patient baseline characteristics n (%)
Group A(n= 44)Group B(n= 39)Pvalue
Age (mean ± SD) (yr)45.4 ± 15.245.1 ± 15.30.916
Gender M:F16:2816:230.663
Duration of symptoms (yr)4.68 ± 7.793.85 ± 4.210.552
Esophageal manifestations28 (63.6)29 (74.4)0.293
Regurgitation and heartburn21 (47.7)23 (59.0)0.306
Epigastric pain8 (18.2)9 (23.1)0.581
Nausea7 (15.9)6 (15.4)0.948
Vomiting 0 (0)1 (2.6)0.285
Extra-esophageal manifestations38 (86.4)33 (84.6)0.821
Chest pain16 (36.4)10 (25.6)0.293
Globus24 (54.5)16 (41.0)0.219
Hoarseness15 (34.1)10 (25.6)0.402
Metallic taste22 (50.0)16 (41.0)0.413
Nocturnal cough17 (38.6)09 (23.1)0.127
Dyspnea21 (47.7)20 (51.3)0.746
Sore throat20 (45.5)13 (33.3)0.260
Thick sputum production24 (54.5)13 (33.3)0.052
Mixed symptoms25 (56.8)24 (61.5)0.663
Table 2 Subjective global symptom assessment n (%)
BetterSameWorseTotal
Group A20 (71.4)7 (25.0)1 (3.6)28
Group B17 (65.4)8 (30.8)1 (3.8)26
Total3715254